OMER Q4 2017 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M+6.6% YoY

Gross Profit

$13M96.6% margin

Operating Income

-$14M-102.6% margin

Net Income

-$17M-120.3% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-36.5%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$116M

Total Liabilities

$119M

Stockholders' Equity

-$3M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$13M	+6.6%
Gross Profit	$13M	$13M	+6.1%
Operating Income	-$14M	-$12M	-19.1%
Net Income	-$17M	-$20M	+15.7%